BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Simitsopoulou M, Roilides E, Dotis J, Dalakiouridou M, Dudkova F, Andreadou E, Walsh TJ. Differential expression of cytokines and chemokines in human monocytes induced by lipid formulations of amphotericin B. Antimicrob Agents Chemother 2005;49:1397-403. [PMID: 15793118 DOI: 10.1128/AAC.49.4.1397-1403.2005] [Cited by in Crossref: 42] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Dotis J, Simitsopoulou M, Dalakiouridou M, Konstantinou T, Taparkou A, Kanakoudi-Tsakalidou F, Walsh TJ, Roilides E. Effects of lipid formulations of amphotericin B on activity of human monocytes against Aspergillus fumigatus. Antimicrob Agents Chemother 2006;50:868-73. [PMID: 16495244 DOI: 10.1128/AAC.50.3.868-873.2006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
2 J B, M BM, Chanda K. An Overview on the Therapeutics of Neglected Infectious Diseases-Leishmaniasis and Chagas Diseases. Front Chem 2021;9:622286. [PMID: 33777895 DOI: 10.3389/fchem.2021.622286] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
3 Yagnik D, Serafin V, J Shah A. Antimicrobial activity of apple cider vinegar against Escherichia coli, Staphylococcus aureus and Candida albicans; downregulating cytokine and microbial protein expression. Sci Rep 2018;8:1732. [PMID: 29379012 DOI: 10.1038/s41598-017-18618-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
4 Faustino C, Pinheiro L. Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy. Pharmaceutics 2020;12:E29. [PMID: 31906268 DOI: 10.3390/pharmaceutics12010029] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 15.5] [Reference Citation Analysis]
5 Fujita T, Yoshimoto T, Kajiya M, Ouhara K, Matsuda S, Takemura T, Akutagawa K, Takeda K, Mizuno N, Kurihara H. Regulation of defensive function on gingival epithelial cells can prevent periodontal disease. Jpn Dent Sci Rev 2018;54:66-75. [PMID: 29755617 DOI: 10.1016/j.jdsr.2017.11.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
6 Olson JA, Schwartz J, Hahka D, George A, Proffitt RT, Adler-Moore JP. Differences in efficacy and cytokine profiles following echinocandin or liposomal amphotericin B monotherapy or combination therapy for murine pulmonary or systemic Aspergillus flavus infections. Antimicrob Agents Chemother 2012;56:218-30. [PMID: 21968353 DOI: 10.1128/AAC.00607-11] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Burza S, Sinha PK, Mahajan R, Sanz MG, Lima MA, Mitra G, Verma N, Das P. Post Kala-Azar dermal leishmaniasis following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) for primary visceral leishmaniasis in Bihar, India. PLoS Negl Trop Dis 2014;8:e2611. [PMID: 24392171 DOI: 10.1371/journal.pntd.0002611] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
8 Baracaldo-santamaría D, Cala-garcia JD, Medina-rincón GJ, Rojas-rodriguez LC, Calderon-ospina C. Therapeutic Drug Monitoring of Antifungal Agents in Critically Ill Patients: Is There a Need for Dose Optimisation? Antibiotics 2022;11:645. [DOI: 10.3390/antibiotics11050645] [Reference Citation Analysis]
9 Moen MD, Lyseng-Williamson KA, Scott LJ. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections. Drugs 2009;69:361-92. [PMID: 19275278 DOI: 10.2165/00003495-200969030-00010] [Cited by in Crossref: 199] [Cited by in F6Publishing: 169] [Article Influence: 15.3] [Reference Citation Analysis]
10 Stergiopoulou T, Meletiadis J, Sein T, Papaioannidou P, Walsh TJ, Roilides E. Synergistic interaction of the triple combination of amphotericin B, ciprofloxacin, and polymorphonuclear neutrophils against Aspergillus fumigatus. Antimicrob Agents Chemother 2011;55:5923-9. [PMID: 21911564 DOI: 10.1128/AAC.00548-11] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
11 Sun HY, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, del Busto R, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Munoz P, Kalil AC, Garcia-Diaz J, Orloff S, House AA, Houston S, Wray D, Huprikar S, Johnson LB, Humar A, Razonable RR, Husain S, Singh N. Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis. Clin Infect Dis 2009;49:1721-8. [PMID: 19886800 DOI: 10.1086/647948] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
12 Beaver R, Garza B, Vallabhaneni H, Cahuayme-Zuniga L, Midturi J, LaDow T. Use of topical amphotericin in a case of refractory sino-orbital angioinvasive mucormycosis. Med Mycol Case Rep 2021;33:21-5. [PMID: 34295641 DOI: 10.1016/j.mmcr.2021.06.003] [Reference Citation Analysis]
13 Mesa-Arango AC, Scorzoni L, Zaragoza O. It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug. Front Microbiol 2012;3:286. [PMID: 23024638 DOI: 10.3389/fmicb.2012.00286] [Cited by in Crossref: 112] [Cited by in F6Publishing: 104] [Article Influence: 11.2] [Reference Citation Analysis]
14 Clemons KV, Schwartz JA, Stevens DA. Experimental central nervous system aspergillosis therapy: efficacy, drug levels and localization, immunohistopathology, and toxicity. Antimicrob Agents Chemother 2012;56:4439-49. [PMID: 22687510 DOI: 10.1128/AAC.06015-11] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
15 Hamill RJ. Amphotericin B formulations: a comparative review of efficacy and toxicity. Drugs 2013;73:919-34. [PMID: 23729001 DOI: 10.1007/s40265-013-0069-4] [Cited by in Crossref: 316] [Cited by in F6Publishing: 282] [Article Influence: 39.5] [Reference Citation Analysis]
16 Pai MP, Norenberg JP, Telepak RA, Sidney DS, Yang S. Assessment of effective renal plasma flow, enzymuria, and cytokine release in healthy volunteers receiving a single dose of amphotericin B desoxycholate. Antimicrob Agents Chemother 2005;49:3784-8. [PMID: 16127053 DOI: 10.1128/AAC.49.9.3784-3788.2005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]